Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature.
Hiroki WakabayashiHitoshi KinoMakoto KondoKeiichi YamanakaMasahiro HasegawaAkihiro SudoPublished in: BMC rheumatology (2019)
Tocilizumab may be effective in patients with RA and SSc overlap syndrome for which conventional treatment is inadequate. Further research is needed because this report included only two patients.
Keyphrases
- systemic sclerosis
- rheumatoid arthritis
- interstitial lung disease
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- juvenile idiopathic arthritis
- rheumatoid arthritis patients
- case report
- peritoneal dialysis
- disease activity
- systemic lupus erythematosus
- combination therapy
- patient reported